News

Trispecific antibodies show exceptionally promising results against HIV.

Alnylam Therapeutics expects to file for a New Drug Application in late 2017.

Buprenorphine and methadone — while linked to increased risk of serious side effects — are more beneficial than harmful when combined with benzodiazepines or other central nervous system depressants for opioid addiction care.

The ED34-i10T model includes a single-use, detachable and disposable distal cap, a simplified interface, ergonomic and image quality improvements, and reduced length.

HCV-positive women of childbearing age undergo premature ovarian deterioration, researchers wrote.

Analysis of omalizumab trials has identified asthma patients who are most likely to respond to treatment.

Results from "real word" asthma treatment with omalizumab correspond to clinical trial findings and suggest that FeNO values can help predict treatment response.

All of the 13 patients with genotype 2 achieved SVR after 12 weeks of treatment, and in those with genotype 3, the SVR rate was 97%.

While previous research has shown a link between eating meat and the risk of developing type 2 diabetes, a new study is the first to evaluate the risk in people eating an eastern diet.

A new study finds optic neuritis results in structural changes in the eye in MS patients, though it doesn’t appear to affect vision quality.

While HRT has been in and out of favor, for the right patient, hormone therapy is safe and effective.

Valbenazine a breakthrough for patients treated empirically to date.

While 52% of patients were eligible for treatment, only 60% of them received it. For the 47% of individuals who weren’t eligible, the most common reason was their inability to provide pre-treatment workups including serologic testing and assessment for liver fibrosis and inflammation.

The combination is the first once-daily therapy approved in the US that combines 3 active molecules in a single inhaler.

The ongoing phase 3 trial has been selected for accelerated approval pathways in the US and Europe.

A flexible Bayesian variable selection model was crafted for accounting for functional annotations of genetic variants for identifying risk signals.

It is the first and only single oral dose drug approved for the most common gynecologic infection.

Truvada showed efficacy and safety in HIV-susceptible teenage boys — so as long as they kept up with treatment.

While the causes of MDD and bipolar disorder are unknown, there are clues that genetics play a role.

Hepatitis C drug treatment resistance can be met and defeated by longer treatment or additional agent.

The marker could serve in treatment trials in lieu of participants prone to exacerbation and the accompanying morbidity and risk of death.

Patient-driven doses led to 67.5% of subjects reaching target HbA1C compared to 58.4% in the physician-driven arm.

Bronchial thermoplasty was found comparable to omalizumab in an indirect comparison of their effectiveness for uncontrolled, severe asthma.

The treatment is a once-daily, extended-release liquid medication, but does not require refrigeration or pharmacy reconstitution.

AbbVie filed for elagolix approval to treat endometriosis-associated pain, and current studies are testing the same drug effectiveness for uterine fibroids.

BRIVIACT and Aptiom were both previously approved for more particular indications in partial-onset seizure treatment.

Produced by GlaxoSmithKline, 100 mg mepolizumab used in conjunction with maximal guideline-recommended therapy, showed a consistent 18% to 20% reduction.

Stay connected and up-to-date in health care news with the Connected Clinician top stories of the week for the week of September 15.

The single-dose inhaler was the first of its kind to get positive recommendation from EMA's Committee for Medicinal Products for Human Use.

After adjusting for comorbidities, education level, birthplace, and duration of diabetes, the data showed that men with T1D faced a slightly higher risk of AFib, but women with T1D faced a 50% higher risk of developing AFib.